Patients with uncontrolled components of metabolic syndrome have increased risk of complications following total joint arthroplasty

Journal of Arthroplasty

Volumn 28, Issue 6, 2013, Pages 904-907

  Zmistowski, Benjamin ^a   Dizdarevic, Ismar ^a   Jacovides, Christina L ^a   Radcliff, Kris E ^a   Mraovic, Boris ^b   Parvizi, Javad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Complications; Diabetes; Dyslipidemia; Hypertension; Total joint arthroplasty; Uncontrolled metabolic syndrome

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CONTROL; DISLOCATION; DYSLIPIDEMIA; FEMALE; HEART DISEASE; HEMATOMA; HUMAN; HYPERTENSION; LENGTH OF STAY; LUNG EMBOLISM; MALE; METABOLIC SYNDROME X; MUSCLE NECROSIS; PATIENT SAFETY; PERIPROSTHETIC FRACTURE; PERIPROSTHETIC JOINT INFECTION; PEROPERATIVE COMPLICATION; SMALL INTESTINE OBSTRUCTION; SURGICAL RISK; URINARY TRACT INFECTION; WOUND COMPLICATION;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84878199227     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.12.018     Document Type: Article

References (36)

1. Kurtz S., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89(4):780. Available at: [Accessed December 1, 2009].
2. Parvizi J., Pulido L., Purtill J.J., et al. Metabolic Syndrome Increases the Risk for Pulmonary Embolism after Joint Arthroplasty. J Arthroplasty 2008, 23(2):327. Available at: [Accessed May 2, 2010].
3. Gandhi R., Razak F., Tso P., et al. Metabolic syndrome and the incidence of symptomatic deep vein thrombosis following total knee arthroplasty. J Rheumatol 2009, 36(10):2298. Available at: [Accessed May 2, 2010].
4. Levin P.D., Weissman C. Obesity, metabolic syndrome, and the surgical patient. Med Clin North Am 2009, 93(5):1049. Available at: [Accessed May 2, 2010].
5. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287(3):356. Available at: [Accessed May 2, 2010].
6. Muntner P., He J., Chen J., et al. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 2004, 14(9):686. Available at: [Accessed May 2, 2010].
7. Li W., Ma D., Liu M., et al. Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 2008, 25(6):539. Available at: [Accessed May 2, 2010].
8. Kajimoto K., Miyauchi K., Kasai T., et al. Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009, 137(3):658. Available at: [Accessed May 2, 2010].
9. Ninomiya T., Kiyohara Y., Kubo M., et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006, 48(3):383. Available at: [Accessed May 2, 2010].
10. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004, 140(3):167. Available at: [Accessed May 2, 2010].
11. Kurella M., Lo J.C., Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005, 16(7):2134. Available at: [Accessed May 2, 2010].
12. Rojas-Rodríguez J., Escobar-Linares L.E., Garcia-Carrasco M., et al. The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis. Med Hypotheses 2007, 69(4):860. Available at: [Accessed May 2, 2010].
13. Marchant M.H., Viens N.A., Cook C., et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am 2009, 91(7):1621. Available at: [Accessed May 1, 2010].
14. Alberti K.G.M.M., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640. Available at: [Accessed May 3, 2010].
15. Anon, Care Diabetes Executive summary: standards of medical care in diabetes--2009. Diabetes Care 2009, 32(Suppl 1):S6. Available at: [Accessed May 2, 2010].
16. Primatesta P., Brookes M., Poulter N.R. Improved Hypertension Management and Control. Hypertension 2001, 38(4):827. Available at: [Accessed July 15, 2011].
17. Anon Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486. Available at: [Accessed July 15, 2011].
18. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373. Available at: [Accessed May 2, 2010].
19. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45(6):613. Available at: [Accessed May 2, 2010].
20. Ay C., Tengler T., Vormittag R., et al. Venous thromboembolism-a manifestation of the metabolic syndrome. Haematologica 2007, 92(3):374. Available at: [Accessed May 4, 2010].
21. Ageno W., Prandoni P., Romualdi E., et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006, 4(9):1914. Available at: [Accessed May 4, 2010].
22. Jämsen E., Nevalainen P., Eskelinen A., et al. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 2012, 94(14):e101.
23. Aspden R.M., Scheven B.A., Hutchison J.D. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001, 357(9262):1118. Available at: [Accessed May 4, 2010].
24. Rutter M.K., Meigs J.B., Sullivan L.M., et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004, 110(4):380. Available at: [Accessed May 4, 2010].
25. Wee C.C., Mukamal K.J., Huang A., et al. Obesity and C-reactive protein levels among white, black, and hispanic US adults. Obesity (Silver Spring) 2008, 16(4):875. Available at: [Accessed May 4, 2010].
26. Onat A., Can G., Hergenç G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metab. Clin. Exp. 2008, 57(2):207. Available at: [Accessed May 4, 2010].
27. Durina J., Remkova A. Prothrombotic state in metabolic syndrome. Bratisl Lek Listy 2007, 108(6):279. Available at: [Accessed May 4, 2010].
28. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006, 21(1):1. Available at: [Accessed May 4, 2010].
29. In Y., Kong C.-G., Kim J.-M., et al. Effect of total knee arthroplasty on metabolic syndrome. J Arthroplasty 2010, 25(7):1110. Available at: [Accessed July 29, 2011].
30. Romanelli R.J., Schiro T.A., Jukes T., et al. Disparities in blood pressure control within a community-based provider network: an exploratory analysis. Ann Pharmacother 2011, 45(12):1473.
31. Colby J.A., Wang F., Chhabra J., et al. Predictors of medication adherence in an urban Latino community with healthcare disparities. J Immigr Minor Health 2012, 14(4):589.
32. Shelley D., Tseng T.-Y., Andrews H., et al. Predictors of blood pressure control among hypertensives in community health centers. Am J Hypertens 2011, 24(12):1318.
33. Axon R.N., Gebregziabher M., Echols C., et al. Racial and ethnic differences in longitudinal blood pressure control in veterans with type 2 diabetes mellitus. J Gen Intern Med 2011, 26(11):1278.
34. Gandhi R., Razak F., Davey J.R., et al. Metabolic syndrome and the functional outcomes of hip and knee arthroplasty. J Rheumatol 2010, 37(9):1917. Available at: [Accessed November 27, 2010].
35. Tillin T., Forouhi N., Johnston D.G., et al. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005, 48(4):649. Available at: [Accessed May 4, 2010].
36. Banerjee D., Misra A. Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? Controversies and suggestions. Int J Obes (Lond) 2007, 31(9):1340. Available at: [Accessed May 4, 2010].